Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Innoviva Inc.

Latest From St. Francis Medical Technologies Inc.

European Cost Concerns May Impact Device Sales

This article is reprinted from the July/August issue of In Vivo.

Vertebral Compression Fracture Market Update: New Products Gain Traction

Vertebral compression fracture repair remains one of the fastest growing segments of the spinal market. Although the VCF industry as a whole remains strong, competitive dynamics in this industry are beginning to shift, with a growing number of new products now available to address this expanding market.
Medical Device

Artificial Discs: Where Do We Go from Here?

Artificial discs are experiencing a cooling trend owing to an expected reduction in CMS reimbursement for both cervical and lumbar disc replacement. Many motion preservation companies are reaching critical regulatory milestones that will likely require a step-up in funding to conduct the large scale clinical studies needed to gain PMA approval. Today, companies in this sector are faced with the troubling task of either scaling back R&D programs to conserve cash or raising additional capital to take the next steps. This article first appeared in the June 2008 issue of In Vivo.
Medical Device

Spine Market: Are the Good Times Over?

The global market for spine implants and products will surpass $6 billion this year. While technological innovations continue to abound and industry proponents forecast sustained double-digit growth, the spine market is entering an unsettling phase of bureaucratic regulation and oversight from regulators and payors who appear intent on putting the breaks on this sector.
Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Respiratory, Pulmonary
  • Alias(es)
  • Advanced Medicine Inc.
  • Theravance Inc.
  • Theravance Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Innoviva Inc.
  • Senior Management
  • Michael W Aguiar, Pres. & CEO
    Eric d'Esparbes, CFO
    Michael Faerm, SVP, CBO
    George B Abercrombie, SVP, Chief Commercial Officer
    Theodore J Witek, SVP, CSO
  • Contact Info
  • Innoviva Inc.
    Phone: (650) 808-6000
    951 Gateway Blvd.
    South San Francisco, CA 94080